Brief: Glucotrack To File Significant Ide With FDA For Us Clinical Trial In Early Q2 Based On Critical 2025 Milestones
27/03/2026 12:10
GlucoTrack Inc GCTK.O: GLUCOTRACK TO FILE SIGNIFICANT IDE WITH FDA FOR US CLINICAL TRIAL IN EARLY Q2 BASED ON CRITICAL 2025 MILESTONES Source text: ID:nGNXQnDNM Further company coverage: GCTK.O